The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue

Abstract

Fatigue symptoms are reported by a majority of patients with multiple sclerosis (MS). Reliable assessment, however, is a demanding issue as the symptoms are experienced subjectively and as objective assessment strategies are missing. The objective of this study was to develop and validate a new tool, the Fatigue Scale for Motor and Cognitive Functions (FSMC), for the assessment of MS-related cognitive and motor fatigue. A total of 309 MS patients and 147 healthy controls were included into the validation study. The FSMC was tested against several external criteria (e.g. cognition, motivation, personality and other fatigue scales). The item-analysis and validation procedure showed that the FSMC is highly sensitive and specific in detecting fatigued MS patients, that both subscales significantly differentiated between patients and controls (p < 0.01), and that internal consistency (Cronbach’s alpha α > 0.91) as well as test—retest reliability (r > 0.80) were high. Cut-off values were determined to classify patients as mildly, moderately or severely fatigued. In conclusion, the FSMC is a new scale that has undergone validation based on a large sample of patients and that provides differential quantification and graduation of cognitive and motor fatigue.

Keywords

fatigue fatigue assessment fatigue scales cognitive fatigue motor fatigue multiple sclerosis patient reported outcome measure

Get full access to this article

View all access options for this article.

References

Krupp LB , Coyle PK , Doscher C. , et al. Fatigue therapy in multiple sclerosis: Results of a double blind, randomised parallel trial of amantadine, pemoline and placebo. Neurology 1995; 45: 1956-1961.

Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America, 1998.

Comi G. , Leocani L. , Rossi P. , et al. Physiopathology and treatment of fatigue in multiple sclerosis . J Neurol 2001; 248: 174-179.

Fisk JD , Pontefract A. , Ritvo PG , Archibald CJ , Murray TJ The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.

Freal JE , Kraft GH , Coryell JK Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984; 65: 135-138.

Jongbloed L. Disability income: The experiences of women with multiple sclerosis. Can J Occup Ther Physiother 1998; 65: 193-201.

Lienert GA , Raatz U. Testaufbau und Testanalyse. Weinheim: Psychologie Verlags Union, 1998, p.220-271.

Krupp LB , LaRocca NG , Muir-Nash J. , Steinberg AD The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.

Schwartz JE , Jandorf L. , Krupp LB The measurement of fatigue: A new instrument. J Psychosom Res 1993; 37: 753-762.

10.

Chalder T. , Berelowitz G. , Pawlikowska T. , et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-153.

11.

Paul RH , Beatty WW , Schneider R. , et al. Cognitive and physical fatigue in multiple sclerosis: Relations between self-report and objective performance. Appl Neuropsychol 1998; 5: 143-148.

12.

DeLuca J. Fatigue: Its definition, its study and its future. In: DeLuca J (ed.) Fatigue as a window to the brain. Cambridge, MA: MIT Press, 2005, p.319-325.

13.

Wessely S. , Hotopf M. , Sharpe M. Chronic fatigue and its syndromes. Oxford: Oxford University Press, 1998.

14.

Beck AT , Ward CH , Mendelson M. , Mock J. , Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.

15.

Rao SM Cognitive Function Study Group. A manual battery for the brief, repeatable battery of neuropsychological tests in MS. New York: National Multiple Sclerosis Society, 1990.

16.

Scherer P. , Penner IK , Rohr A. , et al. The Faces Symbol Test: a newly developed sensitive neuropsychological screening instrument for cognitive decline related to multiple sclerosis - first results of the Berlin Multi-Centre FST Validation Study. Mult Scler 2007; 13: 402-411.

17.

Benedict RHB , Munschauer F. , Linn R. , et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9: 95-101.

18.

Cutter GR , Baier ML , Rudick RA , et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 ; 122: 871-882.

19.

Cumming G. , Finch S. Inference by eye. Confidence intervals and how to read pictures of data. Am Psychol 2005; 60: 170-180.

20.

Ford H. , Trigwell P. , Johnson M. The nature of fatigue in multiple sclerosis. J Psychosom Res 1998; 45: 33-38.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB